Cellular Robustness Conferred by Genetic Crosstalk Underlies Resistance against Chemotherapeutic Drug Doxorubicin in Fission Yeast

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Tay, Zoey ^a,b   Eng, Ru Jun ^a,b   Sajiki, Kenichi ^c   Lim, Kim Kiat ^a,b   Tang, Ming Yi ^a,b   Yanagida, Mitsuhiro ^c   Chen, Ee Sin ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ANTIFUNGAL RESISTANCE; ARTICLE; CELL METABOLISM; CELL STRESS; CELL SURVIVAL; CELL VIABILITY; CHROMOSOME SEGREGATION; CONTROLLED STUDY; GENE DISRUPTION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; MEMBRANE TRANSPORT; MITOCHONDRIAL RESPIRATION; MOLECULAR INTERACTION; NONHUMAN; SCHIZOSACCHAROMYCES POMBE; UPREGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; CELL NUCLEUS; CELL RESPIRATION; CHROMOSOMES, FUNGAL; DOXORUBICIN; DRUG RESISTANCE, FUNGAL; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION, FUNGAL; MICROBIAL VIABILITY; MITOCHONDRIA; SCHIZOSACCHAROMYCES; SCHIZOSACCHAROMYCES POMBE PROTEINS;

SCHIZOSACCHAROMYCES POMBE; SCHIZOSACCHAROMYCETACEAE;

EID: 84872855089     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055041     Document Type: Article

References (33)

1. Hanušová V, Boušová I, Skálová L, (2011) Possibilities to increase the effectiveness of doxorubicin in cancer cells killing. Drug Metab Rev 43: 540-557.
2. Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, et al. (2009) Doxorubicin: The good, the bad and the ugly effect. Curr Med Chem 16: 3267-3285.
3. Pommier Y, Leo E, Zhang H, Marchand C, (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17: 421-433.
4. Wang JC, (2002) Cellular roles of DNA topoisomerases: A molecular perspective. Nat Rev Mol Cell Biol 3: 430-440.
5. Bilardi RA, Kimura KI, Phillips DR, Cutts SM, (2012) Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways. Biochem Pharmacol 83: 1241-1250.
6. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM, (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5: 219-234.
7. Ma Y, Jiang Y, Liu Q, Ryuko S, Kuno T, (2011) Genome-wide screening for genes associated with FK506 sensitivity in fission yeast. PLos ONE 6: e23422.
8. Dawson K, Toone WM, Jones N, Wilkinson CR, (2008) Loss of regulators of vacuolar ATPase function and ceramide synthesis results in multidrug sensitivity in Schizosaccharomyces pombe. Eukaryot Cell 7: 926-937.
9. Hogan CJ, Aligianni S, Durand-Dubief M, Persson J, Will WR, et al. (2010) Fission yeast Iec1-Ino80-mediated nucleosome eviction regulates nucleotide and phosphate metabolism. Mol Cell Biol 30: 657-674.
10. Monahan BJ, Villen J, Marguerat S, Bahler J, Gygi SP, et al. (2008) Fission yeast SWI/SNF and RSC complexes show compositional and functional differences from budding yeast. Nat Struct Mol Biol 15: 873-880.
11. Helmlinger D, Marguerat S, Villen J, Gygi SP, Bahler J, et al. (2008) The S. pombe SAGA complex controls the switch from proliferation to sexual differentiation through the opposing roles of its subunits Gcn5 and Spt8. Genes Dev 22: 3184-3195.
12. Liu X, McLeod I, Anderson S, Yates JR 3rd, He X (2005) Molecular analysis of kinetochore architecture in fission yeast. EMBO J 24: 2919-2130.
13. Kawamukai M, (2009) Biosynthesis and bioproduction of coenzyme Q10 by yeasts and other organisms. Biotechnol. Appl Biochem 53: 217-226.
14. Dixon SJ, Costanzo M, Baryshnikova A, Andrews B, Boone C, (2009) Systematic mapping of genetic interaction networks. Annu Rev Genet 43: 601-625.
15. Khasanov FK, Savchenko GV, Bashkirova EV, Korolev VG, Heyer W, et al. (1999) A new recombinational DNA repair gene from Schizosaccharomyces pombe with homology to Escherichia coli RecA. Genetics 152: 1557-1572.
16. Rogeuv A, Bandyopadhyay S, Zofall M, Zhang K, Fischer T, et al. (2008) Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast. Science 322: 405-410.
17. Cavero S, Limbo O, Russell P, (2010) Critical functions of Rpa3/Ssb3 in S-phase DNA damage responses in fission yeast. PLos Genet 6: e1001138.
18. Raji H, Hartsuiker E, (2006) Double-strand break repair and homologous recombination in Schizosaccharomyces pombe. Yeast 23: 963-976.
19. Stelling J, Sauer U, Szallasi Z, Doyle FJ 3rd, Doyle J (2004) Robustness of cellular functions. Cell 118: 675-685.
20. Kitano H, (2010) Towards a theory of biological robustness. Mol Syst Biol 6: 384.
21. Szalay MS, Kovács IA, Korcsmáros T, Böde C, Csermely P, (2007) Stress-induced rearrangements of cellular networks: consequences for protection and drug design. FEBS Lett 581: 3675-3680.
22. Xia L, Jaafar L, Cashikar A, Flores-Rozas H, (2007) Identification of genes required for protection from doxorubicin by a genome-wide screen in Saccharomyces cerevisiae. Cancer Res 67: 11411-11418.
23. Bao Y, Shen X, (2007) Chromatin remodeling in DNA double-stranded break repair. Curr Opin Genet Dev 17: 126-131.
24. Gospodinov A, Vaissiere T, Krastex DB, Legube G, Anachkova B, et al. (2011) Mammalian Ino80 mediates double-stranded break repair through its role in DNA end strand resection. Mol Cell Biol 31: 4735-4745.
25. van Attikum H, Fritsch O, Gasser SM, (2007) Distinct roles of SWR1 and INO80 chromatin remodeling complexes at chromosomal double-stranded breaks. EMBO J 26: 4113-4125.
26. Singh TR, Saro D, Ali AM, Zheng X, Du C, et al. (2010) MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. Mol Cell 26: 879-886.
27. Tokarska-Schlattner M, Wallimann T, Schlattner U, (2006) Alterations in myocardial energy metabolism induced by anti-cancer drug doxorubicin. C R Biol 329: 657-668.
28. Brea-Calvo G, Rodríguez-Hernández A, Fernández-Ayala DJ, Navas P, Sánchez-Alcázar JA, (2006) Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines. Free Radic Biol Med 40: 1293-1302.
29. Conklin KA, (2005) Coenzyme q10 for prevention of anthracycline-induced cytotoxicity. Integr Cancer Ther 4: 110-130.
30. Sharom FJ, (2011) The P-glyoprotein multidrug transporter. Essays Biochem 50: 161-178.
31. Abbasi M, Lavasanifar A, Uluda H (2011) Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer. Med Res Rev doi 10.1002/med.20244.
32. Pajic M, Iyer JK, Kersbergen A, van der Burg E, Nygren AO, et al. (2009) Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer. Cancer Res 69: 6396-6404.
33. Baguley BC, (2010) Multidrug resistance in cancer. Methods Mol Biol 596: 1-14.